EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes

Maite E Del Valle Rolón iD, Elizabeth A Brown, Risa M Wolf iD

Pediatric Diabetes · 05.10.2023 · 2023 · 1-7

DOI: 10.1155/2023/6621706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Diabetes, erschienen am 05.10.2023. Verfasst von Maite E Del Valle Rolón und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Glycemic Control, Insulin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of hybrid closed-loop insulin delivery systems, specifically the t:slim X2 insulin pump with Control IQ (CIQ), has demonstrated improvement in glycemic control in clinical trials and real-world settings. We sought to describe changes in glycemic control with use of CIQ in minority and nonminority youth. Research Design and Methods. This was a retrospective study of youth with type 1 diabetes (T1D) using CIQ over a 12-month period. Medical record data, pump data, and hemoglobin A1c (HbA1c) were collected from the visit prior to starting CIQ and at each clinic visit up to 12 months after starting CIQ. Continuous glucose monitor (CGM) data and HbA1c trajectory over time were compared to baseline and between minority and nonminority youth.

Results

The study included 136 patients of whom 21 were minority youth (non-Hispanic Black and Hispanic), 50% were male, with median age of 13.3y, and median diabetes duration of 4.9y. After starting CIQ, baseline median HbA1c for the nonminority group decreased from 7.8% to 7.1% ( p < 0.001 ), baseline median HbA1c for minority youth decreased from 9.8% to 7.8% ( p = 0.03 ), and the percentage of patients meeting target HbA1c

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsGlycemic ControlInsulinHypoglycemic AgentsHumansMaleFemaleAdolescentRetrospective StudiesChildGlycated HemoglobinBlood GlucoseBlood Glucose Self-Monitoring

Substanzen

Glycated HemoglobinBlood GlucoseInsulinHypoglycemic Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA.

ORCID-Profile: Maite E Del Valle Rolón, Risa M Wolf

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Del Valle Rolón, M. E., Brown, E. A., & Wolf, R. M. (2023). Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes. Pediatric Diabetes, 2023, 1-7. https://doi.org/10.1155/2023/6621706

Vancouver

Del Valle Rolón ME, Brown EA, Wolf RM. Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes. Pediatric Diabetes. 2023;2023:1-7. doi:10.1155/2023/6621706

BibTeX
@article{DelValleRoln2023,
  author = {Del Valle Rolón, Maite E and Brown, Elizabeth A and Wolf, Risa M},
  title = {Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes},
  journal = {Pediatric Diabetes},
  year = {2023},
  volume = {2023},
  pages = {1--7},
  doi = {10.1155/2023/6621706}
}
Kostenlos starten →